Neumora Therapeutics, Inc. (NMRA) Tops Q1 EPS by 4c

Neumora Therapeutics, Inc. (NASDAQ: NMRA) reported Q1 EPS of ($0.42), $0.04 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Neumora Therapeutics, Inc. (NMRA) click here.

You May Also Be Interested In

• JPMorgan Upgrades Diploma Plc. (DPLM:LN) to Overweight
• JPMorgan Starts Jersey Mike's Subs (JMKE) at Overweight
• UBS Downgrades Banco Santander Brasil SA (SANB11:BZ) (BSBR) to Neutral